jump to navigation

Bought NUVA NuVasive for its minimally invasive spine surgery technology July 2, 2018

Posted by deminvest in growth stock, investment, Nasdaq stock, Single stocks, stock I own, stocks.
Tags: ,
add a comment

07/02/2018 13:18:40 Buy 30 NUVA Limit 51.10 DAY Bought @ 51.0899

Data is so so:

There has just been a negative surprise quarter.

This would look nice. If true:

Trailing P/E 63.74
Forward P/E 1 18.32

This doesn’t look heathy for a tech stock:

Quarterly Revenue Growth (yoy) 4.60%

This is bad as well for a tech company that should use cash able to invest, not to pay interests:

Total Debt (mrq) 642.72M


Next time I should write first, buy the stock second.

%d bloggers like this: